Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement.
Across FY2022–FY2025: $12.25M in buybacks, $8.92M in dividends.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
Issuer evidence: INDENTURE dated as of January 14, 2026 among CompoSecure, Inc., a Delaware corporation (the “*Parent* ”), CompoSecure Holdings, L.L.C., a Delaware limited liability company (the “*Issuer*”), the other Guarantors (as defined herein) from time to time party hereto and U.S. Bank Trust Company, National Association, as trustee (in such capacity, the “*Trustee*”) and as collateral agent (in such capacity, the “*Notes Collateral Agent*”).
Supporting evidence: The Issuer, the Guarantors, the Trustee and the Notes Collateral Agent agree as follows for the benefit of each other and for the equal and ratable benefit of the Holders (as defined herein) of the 5.625% Senior Secured Notes due 2033 (the “*Notes*”):
On January 14, 2026, the Company announced the completion of a private placement by its direct, wholly owned subsidiary CompoSecure Holdings, L.L.C. (in such capacity, “the Issuer”) of $900.0 million aggregate principal amount of 5.625% Senior Secured Notes due 2033 (the “2033 Notes”). The 2033 Notes were issued pursuant to an indenture (the “Indenture”), dated as of January 14, 2026 (the “Closing Date”), among the Issuer, the Company, the subsidiary guarantors party thereto from time to time (together with the Company, the “Guarantors”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”) and as notes collateral agent (the “Notes Collateral Agent”).
Issuer evidence: On January 14, 2026, the Company announced the completion of a private placement by its direct, wholly owned subsidiary CompoSecure Holdings, L.L.C. (in such capacity, “the Issuer”) of $900.0 million aggregate principal amount of 5.625% Senior Secured Notes due 2033 (the “2033 Notes”). The 2033 Notes were issued pursuant to an indenture (the “Indenture”), dated as of January 14, 2026 (the “Closing Date”), among the Issuer, the Company, the subsidiary guarantors party thereto from time to time (together with the Company, the “Guarantors”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”) and as notes collateral agent (the “Notes Collateral Agent”).
Supporting evidence: The 2033 Notes bear interest at a fixed rate of 5.625% per annum, accruing from January 14, 2026. Interest is payable semiannually in arrears on February 1 and August 1 of each year, commencing on August 1, 2026. The 2033 Notes will mature on February 1, 2033. The 2033 Notes are senior secured obligations of the Issuer. The 2033 Notes are fully and unconditionally guaranteed, jointly and severally, by each of the Guarantors. The guarantees are senior secured obligations of the Guarantors.
Supporting evidence: On January 14, 2026, the Company announced the completion of a private placement by its direct, wholly owned subsidiary CompoSecure Holdings, L.L.C. (in such capacity, “the Issuer”) of $900.0 million aggregate principal amount of 5.625% Senior Secured Notes due 2033 (the “2033 Notes”). The 2033 Notes were issued pursuant to an indenture (the “Indenture”), dated as of January 14, 2026 (the “Closing Date”), among the Issuer, the Company, the subsidiary guarantors party thereto from time to time (together with the Company, the “Guarantors”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”) and as notes collateral agent (the “Notes Collateral Agent”).
5.625% Senior Secured Notes due 2033
Note · CompoSecure Holdings, L.L.C.
Reference: 5.625% Senior Secured Notes due 2033
Active
Outstanding
—
Commitment
—
Availability
—
Maturity
—
Last reported interest terms:
5.625%
Reported 2026-01-14Later filings may not restate these terms; this does not confirm they still apply.
Covenant terms for this agreement are not yet verified.
WHEREAS, the Issuer has heretofore executed and delivered to the Trustee and the Notes Collateral Agent an indenture (as it may be amended, restated, supplemented or otherwise modified from time to time, the “*Indenture*”), dated as of January 14, 2026, providing for the issuance of 5.625% Senior Secured Notes due 2033 (the “*Notes*”);
Issuer evidence: INDENTURE dated as of January 14, 2026 among CompoSecure, Inc., a Delaware corporation (the “*Parent* ”), CompoSecure Holdings, L.L.C., a Delaware limited liability company (the “*Issuer*”), the other Guarantors (as defined herein) from time to time party hereto and U.S. Bank Trust Company, National Association, as trustee (in such capacity, the “*Trustee*”) and as collateral agent (in such capacity, the “*Notes Collateral Agent*”).
Supporting evidence: WHEREAS, the Issuer has heretofore executed and delivered to the Trustee and the Notes Collateral Agent an indenture (as it may be amended, restated, supplemented or otherwise modified from time to time, the “*Indenture*”), dated as of January 14, 2026, providing for the issuance of 5.625% Senior Secured Notes due 2033 (the “*Notes*”);
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
134,286.48×
Peer median 2.28×
EV/EBIT
—
Peer median 33.37×
P/E (TTM)
—
Peer median 20.80×
EV/Adj. EBITDA (FY2025)
18.88×
Peer median 11.61×
Peer medians compare against the 10 similar-size Metal Fabrication companies (of 17 listed).
EV/Adj. EBITDA uses
the company-stated
“Pro Forma Adjusted EBITDA”,
extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.
Valuation over time computed as of each quarter's filing date
EV/Adj. EBITDA uses
the company-stated
“Pro Forma Adjusted EBITDA”,
extracted from the reconciliation in its SEC filings as it existed at each sample date — the company's own non-GAAP definition, not an XBRL-tagged figure. Each point's tooltip names its TTM or fiscal-year basis.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
